Application Note: Detecting HEK293 residual DNA contamination in your cell or gene therapy products
30 June 2023
Cell and gene therapies begin their development with the help of a host cell line, but before the product can be administered to a patient, any trace
of the host cell DNA must be removed to avoid oncogenic effects. In this application note, Bio-Rad provides an overview of how to detect HEK293 residual DNA contamination in your cell and gene therapy products.
_(1).gif)
.gif)